Skip to main content
. 2021 Oct 11;11:20175. doi: 10.1038/s41598-021-99726-7

Table 2.

Surgical treatment methods.

Group 1 Group 2 Group 3 p
Type of breast surgery
None n (%) 8 (0.9) 6 (8.8) 36 (19.5) < 0.001
Mastectomy 507 (54.6) 53 (77.9) 127 (68.6)
Breast-conserving surgery 413 (44.5) 9 (13.2) 22 (11.9)
Axillary surgery
None n (%) 16 (1.7) 8 (11.8) 39 (21.2) < 0.001
ALND 433 (46.7) 49 (72.1) 112 (60.9)
SLNB 339 (36.6) 9 (13.2) 17 (9.2)
SLNB + ALND 139 (15.0) 2 (2.9) 16 (8.7)
SLNB method
Isosulfan Blue n (%) 67 (14.2) 4 (30.8) 6 (17.1) 0.487
Radiocolloid 93 (19.7) 3 (23.1) 6 (17.1)
Combined 312 (66.1) 6 (46.2) 23 (65.7)
Tumor size (cm) Median (range) 2.2 (0–16) 3 (0.7–16) 3 (0–14) < 0.001
No. of positive SLNs Median (range) 0 (0–11) 0 (0–6) 1 (0–7) 0.049
Number of SLNs removed Median (range) 4 (0–12) 3 (0–8) 4 (1–16) 0.471
No. of lymph nodes removed by ALND Median (range) 15 (1–71) 17 (1–53) 18 (0–57) 0.001
No. of positive nodes in ALND Median (range) 0 (0–44) 6 (0–32) 4 (0–51) < 0.001
Perinodal involvement
No n (%) 514 (79.0) 22 (47.8) 52 (57.8) < 0.001
Yes 137 (21.0) 24 (52.2) 38 (42.2)

ALND axillary lymph node dissection, SLNB sentinel lymph node dissection.